Asian Superspeciality Hospital Enterprises Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 12-01-2025
- Paid Up Capital ₹ 3.40 M
as on 12-01-2025
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.28 M
as on 12-01-2025
- Revenue 4.31%
(FY 2020)
- Profit 17.72%
(FY 2020)
- Ebitda 1.24%
(FY 2020)
- Net Worth 6.52%
(FY 2020)
- Total Assets 3.81%
(FY 2020)
About Asian Superspeciality Hospital Enterprises
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.40 M.
The company currently has active open charges totaling ₹2.28 M.
Pratap Rath and Prakashchandra Rath serve as directors at the Company.
- CIN/LLPIN
U85110OR1998PTC005553
- Company No.
005553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asian Superspeciality Hospital Enterprises?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratap Rath  | Managing Director | 02-Dec-1998 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakashchandra Rath | Director | 01-Apr-2002 | Current |
Financial Performance of Asian Superspeciality Hospital Enterprises.
Asian Superspeciality Hospital Enterprises Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.31% increase. The company also saw a substantial improvement in profitability, with a 17.72% increase in profit. The company's net worth moved up by a moderate rise of 6.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Superspeciality Hospital Enterprises?
In 2020, Asian Superspeciality Hospital Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Jan 2014 | ₹0.80 M | Open |
State Bank Of India Creation Date: 28 May 2012 | ₹1.48 M | Open |
How Many Employees Work at Asian Superspeciality Hospital Enterprises?
Unlock and access historical data on people associated with Asian Superspeciality Hospital Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asian Superspeciality Hospital Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asian Superspeciality Hospital Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
